Corporate Information
Who are we and what do we do?
ReportMyHealth is a web-based service provided by Genseq Ltd., a privately-held personal genomics and health analytics company offering you the opportunity to learn about your genes and health. Through ReportMyHealth services you can discover the disease risk and health conditions that run in your family.
Why are we called ReportMyHealth?
Because our goal is to enable everyone to take advantage of the very latest methods in personalized health assessment in a way that is easy, informative and, ultimately beneficial to health. You can find out more about our Personal Health Risk Assessment here.
The Company
ReportMyHealth is a wholly owned subsidiary of Genseq, a company founded in April 2007 by two successful entrepreneurs Jean-Yves Sireau and Jim Mellon.
Jean-Yves Sireau, a former Hong Kong-based hedge-fund manager, is founder and CEO of BetOnMarkets.com, a leading financial betting firm founded in 1999 with offices in 3 countries and USD 130 million annual turnover. Jean-Yves has extensive experience in software development notably with Perl, C, Linux and open-source technologies. Jean-Yves is CEO of Genseq Ltd. and lends to the Group his experience in substantial software projects.
Jim Mellon, ranked at 117 on the Sunday Times Rich List with a net worth of GBP700 million, is one of the UK's most successful entrepreneurs and owns substantial stakes in a variety of companies including amongst others Charlemagne Capital, Regent Pacific Group Ltd., Betinternet.com, Sleepwell Hotels, Speymill Group, Conister Trust.
Genseq Ltd.'s other shareholders include 30 high net worth individuals of varied and prestigious backgrounds, including hedge fund managers, mining executives, entrepreneurs, and public personalities.
Genseq's team of software developers, bioinformaticians and health-care professionals is headed by Dr. Waqas A. Awan. Dr. Awan holds a PhD in Bioinformatics from Darwin College, University of Cambridge and a Master of Research (M.Res) from the University of Leeds. Dr. Awan has extensive experience in health-care and biology-related research and ensures that Genseq's health risk assessments are state of the art and reflect the latest scientific literature.
Genseq's board of directors also includes Dr. Nicolas Sireau. Nicolas holds a PhD in Media and Communication Science from City University, an MA in Journalism Studies (Distinction) from Westminster University, and MSc in Business Management from the Lyon Graduate School of Business.
Genseq's shares are quoted on the US Pink Sheets under stock symbol GESNF.
17 November 2008 View Articles of Association
Privacy and Security
ReportMyHealth takes extensive and proactive measures to ensure privacy and security. We recognize that your personal information, genetic or otherwise, belongs to you. We make it easy for you to share information with your family, friends or health-care professional. The ReportMyHealth website gives you complete control over how and with whom you share data. You can learn more by reading our Privacy Policy here.